Interesting data point, thanks. Argentina should be able to show data for this as well, though, I wonder why there haven't been equivalent studies here. I see that people who got Sinopharm are being offered a second dose fairly quickly, two of my colleagues (in their 40s) have both doses already, one lives in CABA, the other in PBA.21 July 2020 at 12:17pm
Sinopharm vaccine induces weaker antibody responses against Delta variant. A study presented today concludes that the people who received it had a reduction of 1.38 times compared to the original virus.Un estudio presentado hoy concluye que las personas que la recibieron tuvieron una reducción de 1,38 veces con respecto al virus original - LA NACIONwww.lanacion.com.ar
Argentina is one of the countries that includes it in its vaccination campaign.